The Use of NT-proBNP for Risk Stratification of Incident Cardiorenal Complications in Type 2 Diabetes-The Hong Kong Diabetes Biobank

被引:0
|
作者
Ma, Ronald C. W.
Tam, Claudia H.
Hou, Yong
Jin, Qiao
Lau, Eric S. H.
Ozaki, Risa
Kong, Alice P.
Chow, Elaine
Luk, Andrea
Lim, Cadmon K. P.
Chan, Juliana C.
机构
关键词
D O I
10.2337/db23-1317-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1317-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] NT-PROBNP AND THE RISK OF INCIDENT DIABETES IN WOMEN
    Everett, Brendan
    Cook, Nancy R.
    Mangone, Maria C.
    Bobadilla, Maria
    Rifai, Nader
    Ridker, Paul M.
    Pradhan, Aruna
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E599 - E599
  • [2] Use of sulphonylurea and cancer in type 2 diabetes-The Hong Kong Diabetes Registry
    Yang, Xilin
    So, Wing Yee
    Ma, Ronald C. W.
    Yu, Linda W. Y.
    Ko, Gary T. C.
    Kong, Alice P. S.
    Ng, Vanessa W. S.
    Luk, Andrea O. Y.
    Ozaki, Risa
    Tong, Peter C. Y.
    Chow, Chun-Chung
    Chan, Juliana C. N.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (03) : 343 - 351
  • [3] NT-proBNP: A Potential Cardiorenal Biomarker in the Management of Diabetes
    Komi, Rieko
    Nakadaira, Ikue
    Suzuki, Jun
    Ohoka, Aiko
    Tanaka, Asami
    Takahashi, Masahiro
    Hamano, Kumiko
    [J]. DIABETES, 2012, 61 : A116 - A116
  • [4] Insomnia and incident risk of diabetes related complications in Hong Kong Chinese patients with type 2 diabetes
    Ding, C.
    Zhang, J.
    Lau, E.
    Luk, A.
    Chow, E.
    Ma, R.
    Chan, J.
    Wing, Y.
    Kong, A.
    [J]. DIABETOLOGIA, 2018, 61 : S159 - S160
  • [5] NT-proBNP to Exclude cardiovascular Complications in Patients with Type 2 Diabetes mellitus
    Resl, Michael
    Neuhold, Stephanie
    Prager, Rudolf
    Brath, Helmut
    Francesconi, Claudia
    Luger, Anton
    Pacher, Richard
    Huelsmann, Martin
    Clodi, Martin
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 : S9 - S9
  • [6] NT-proBNP to Exclude cardiovascular Complications in Patients with Diabetes mellitus Type 2
    Resl, M.
    Huelsmann, M.
    Pacher, R.
    Luger, A.
    Clodi, M.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2013, 125 (17-18) : 559 - 559
  • [7] Using NT-ProBNP for risk stratification in individuals with diabetes: a retrospective study from a diabetes centre
    Radha, S.
    Khaled, R.
    Sabbour, H.
    Lessan, N.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [8] Association of statin use and development of renal dysfunction in type 2 diabetes-The Hong Kong Diabetes Registry
    Luk, Andrea O.
    Yang, Xilin
    Ma, Ronald C.
    Ng, Vanessa W.
    Yu, Linda W.
    Lau, Winnie W.
    Ozaki, Risa
    Chow, Francis C.
    Kong, Alice P.
    Tong, Peter C.
    Chan, Juliana C.
    So, Wingyee
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 88 (03) : 227 - 233
  • [9] NT-proBNP and mortality in type 1 diabetes
    Grimmeshave, L.
    Pedersen-Bjergaard, U.
    Kistorp, C.
    Faber, J.
    [J]. DIABETOLOGIA, 2006, 49 : 31 - 31
  • [10] NT-proBNP and mortality in type 1 diabetes
    Grimmeshave, Lise
    Pedersen-Bjergaard, Ulrik
    Kistorp, Caroline
    Faber, Jens
    Thorsteinsson, Birger
    [J]. DIABETES, 2006, 55 : A156 - A157